Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hauser

Showing results (321-330 of 419) with videos related to

Pageof 42
Sort By:
JAMA Neurology|August 13, 2019
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 YearsEster Cantó, Christian Barro, Chao Zhao, et al.
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Genes and Immunity|April 21, 2006
Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African AmericansD Brassat, A A Motsinger, S J Caillier, et al.
Human Molecular Genetics|June 10, 2011
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complexRebecca L Zuvich, William S Bush, Jacob L McCauley, et al.
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Pageof 42

Showing results (321-330 of 419) with videos related to

Sort By:
Pageof 42
JAMA Neurology|August 13, 2019
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 YearsEster Cantó, Christian Barro, Chao Zhao, et al.
JAMA Neurology|June 1, 2016
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple SclerosisNoriko Isobe, Anisha Keshavan, Pierre-Antoine Gourraud, et al.
Nature Medicine|July 7, 2014
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosisFeng Mei, Stephen P J Fancy, Yun-An A Shen, et al.
Genes and Immunity|April 21, 2006
Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African AmericansD Brassat, A A Motsinger, S J Caillier, et al.
Human Molecular Genetics|June 10, 2011
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complexRebecca L Zuvich, William S Bush, Jacob L McCauley, et al.
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Neurology and Therapy|July 13, 2025
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple SclerosisStephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, et al.
Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2025
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomographyHenriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, et al.
Pageof 42